Wu J, Ma S, Sandhoff R, Ming Y, Hotz-Wagenblatt A, Timmerman V, et al. Loss of neurological disease HSAN-I-associated gene SPTLC2 impairs CD8(+) T cell responses to infection by inhibiting T cell metabolic fitness. Immunity. 2019;50:1218–31.e5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Sullivan D, Pearce EL. Expanding the role of metabolism in T cells. Science. 2015;348:976–7.

Article  PubMed  Google Scholar 

Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011;35:871–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balmer ML, Ma EH, Bantug GR, Grahlert J, Pfister S, Glatter T, et al. Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function. Immunity. 2016;44:1312–24.

Article  CAS  PubMed  Google Scholar 

Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S, Harmrolfs K, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med. 2014;20:1327–33.

Article  CAS  PubMed  Google Scholar 

Field CS, Baixauli F, Kyle RL, Puleston DJ, Cameron AM, Sanin DE, et al. Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function. Cell Metab. 2020;31:422–37.e5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Franco F, Tsui Y-C, Xie X, Trefny MP, Zappasodi R, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21:298–308.

Article  PubMed  PubMed Central  Google Scholar 

Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6.

Article  CAS  PubMed  Google Scholar 

Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.

Article  CAS  PubMed  Google Scholar 

Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4:337–42.

Article  CAS  PubMed  Google Scholar 

Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198:1875–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121–33.

Article  CAS  PubMed  Google Scholar 

Beermann C, Jelinek J, Reinecker T, Hauenschild A, Boehm G, Klor HU. Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis. 2003;2:10.

Article  PubMed  PubMed Central  Google Scholar 

St-Onge MP, Jones PJ. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J Nutr. 2002;132:329–32.

Article  CAS  PubMed  Google Scholar 

St-Onge MP, Bosarge A, Goree LL, Darnell B. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008;27:547–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haghikia A, Jorg S, Duscha A, Berg J, Manzel A, Waschbisch A, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity. 2015;43:817–29.

Article  CAS  PubMed  Google Scholar 

Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2:236–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kidani Y, Bensinger SJ, Liver X. receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev. 2012;249:72–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Motojima K. Peroxisome proliferator-activated receptor (PPAR): structure, mechanisms of activation and diverse functions. Cell Struct Funct. 1993;18:267–77.

Article  CAS  PubMed  Google Scholar 

Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 2007;28:551–8.

Article  CAS  PubMed  Google Scholar 

Cresci S. Pharmacogenetics of the PPAR genes and cardiovascular disease. Pharmacogenomics. 2007;8:1581–95.

Article  CAS  PubMed  Google Scholar 

Jay MA, Ren J. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev. 2007;3:33–9.

Article  CAS  PubMed  Google Scholar 

Ganss R. Maternal metabolism and vascular adaptation in pregnancy: the PPAR. Trends in Endocrinology & Metabolism. 2017;28:73–84.

Pontis S, Ribeiro A, Sasso O, Piomelli D. Macrophage-derived lipid agonists of PPAR-alpha as intrinsic controllers of inflammation. Crit Rev Biochem Mol Biol. 2016;51:7–14.

Article  CAS  PubMed  Google Scholar 

Vella S, Conaldi PG, Florio T, Pagano A. PPAR gamma in neuroblastoma: the translational perspectives of hypoglycemic drugs. PPAR Res. 2016;2016:3038164.

Article  PubMed  PubMed Central  Google Scholar 

Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol cell. 1999;3:397–403.

Article  CAS  PubMed  Google Scholar 

Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207–58.

Article  CAS  PubMed  Google Scholar 

Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol. 2000;16:459–81.

Article  CAS  PubMed  Google Scholar 

Cui G, Qin X, Wu L, Zhang Y, Sheng X, Yu Q, et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Investig. 2011;121:658–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 2008;134:97–111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holstein SA, Hohl RJ. Isoprenoids: remarkable diversity of form and function. Lipids. 2004;39:293–309.

Article  CAS  PubMed  Google Scholar 

Maltese WA. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 1990;4:3319–28.

Article  CAS  PubMed  Google Scholar 

Pahan K, Sheikh FG, Namboodiri AM, Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Investig. 1997;100:2671–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunn SE, Youssef S, Goldstein MJ, Prod’homme T, Weber MS, Zamvil SS, et al. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med. 2006;203:401–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okin D, Medzhitov R. The effect of sustained inflammation on hepatic mevalonate pathway results in hyperglycemia. Cell. 2016;165:343–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

York AG, Williams KJ, Argus JP, Zhou QD, Brar G, Vergnes L, et al. Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling. Cell. 2015;163:1716–29.

Article  CAS  PubMed  PubMed Central